دورية أكاديمية
أعرض في EDS

Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion.

التفاصيل البيبلوغرافية
العنوان: Sulfated liposome-based artificial cell membrane glycocalyx nanodecoys for coronavirus inactivation by membrane fusion.
المؤلفون: Li X; MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China., Cheng N; School of Medicine, Zhejiang University, Hangzhou, 310058, China., Shi D; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China., Li Y; MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China., Li C; College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China., Zhu M; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China., Jin Q; MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China., Wu Z; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China., Zhu L; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China., He Y; College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China., Yao H; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, China., Ji J; MOE Key Laboratory of Macromolecule Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.; Shanxi-Zheda Institute of Advanced Materials and Chemical Engineering, Taiyuan, 030032, China.
المصدر: Bioactive materials [Bioact Mater] 2023 Nov 04; Vol. 33, pp. 1-13. Date of Electronic Publication: 2023 Nov 04 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Ke Ai Publishing Country of Publication: China NLM ID: 101685294 Publication Model: eCollection Cited Medium: Internet ISSN: 2452-199X (Electronic) Linking ISSN: 2452199X NLM ISO Abbreviation: Bioact Mater Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Beijing : Ke Ai Publishing
مستخلص: As a broad-spectrum antiviral nanoparticle, the cell membrane nanodecoy is a promising strategy for preventing viral infections. However, most of the cell membrane nanodecoys can only catch virus and cannot induce inactivation, which may bring about a considerably high risk of re-infection owing to the possible viral escape from the nanodecoys. To tackle this challenge, sulfated liposomes are employed to mimic the cell membrane glycocalyx for constructing an artificial cell membrane glycocalyx nanodecoy that exhibits excellent anti-coronavirus activity against HCoV-OC43, wild-type SARS-CoV-2, Alpha and Delta variant SARS-CoV-2 pseudovirus. In addition, this nanodecoy, loaded with surface sulfate groups as SARS-CoV-2 receptor arrays, can enhance the antiviral capability to virus inactivation through destroying the virus membrane structure and transfer the spike protein to postfusion conformation. Integrating bio-inspired recognition and inactivation of viruses in a single supramolecular entity, the artificial cell membrane nanodecoy opens a new avenue for the development of theranostic antiviral nanosystems, whose mass production is favored due to the facile engineering of sulfated liposomes.
Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(© 2023 The Authors.)
References: J Virol. 2004 Jul;78(14):7727-36. (PMID: 15220447)
Cell Res. 2020 Apr;30(4):343-355. (PMID: 32231345)
Nat Struct Mol Biol. 2016 Sep;23(9):853-8. (PMID: 27501535)
Drug Des Devel Ther. 2022 Mar 15;16:685-715. (PMID: 35321497)
Biosensors (Basel). 2022 May 09;12(5):. (PMID: 35624612)
Nature. 2022 Feb;602(7898):671-675. (PMID: 35016199)
Crit Rev Clin Lab Sci. 2020 Sep;57(6):365-388. (PMID: 32645276)
PLoS Pathog. 2018 Aug 13;14(8):e1007236. (PMID: 30102747)
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. (PMID: 29711117)
Nat Commun. 2022 Jul 1;13(1):3716. (PMID: 35778399)
Int J Mol Sci. 2022 Mar 23;23(7):. (PMID: 35408866)
Bionanoscience. 2022;12(1):274-291. (PMID: 35096502)
Annu Rev Med. 2022 Jan 27;73:1-16. (PMID: 34428080)
Antiviral Res. 2011 Jun;90(3):168-82. (PMID: 21439325)
Nano Lett. 2019 Apr 10;19(4):2215-2222. (PMID: 30543300)
Cell. 2022 Jul 7;185(14):2422-2433.e13. (PMID: 35772405)
ACS Nano. 2018 Jul 24;12(7):6429-6442. (PMID: 29894156)
Front Nutr. 2022 Nov 07;9:992733. (PMID: 36419551)
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L211-L217. (PMID: 32519894)
Annu Rev Virol. 2020 Sep 29;7(1):143-165. (PMID: 32396772)
Nat Med. 2021 Dec;27(12):2127-2135. (PMID: 34650248)
Nat Nanotechnol. 2021 Aug;16(8):942-951. (PMID: 34140674)
Biophys Rev. 2022 Mar 7;14(1):111-143. (PMID: 35340604)
J Virol. 2000 Jun;74(11):5116-22. (PMID: 10799586)
Adv Mater. 2018 Nov;30(45):e1802233. (PMID: 30252965)
Curr Opin Struct Biol. 2022 Oct;76:102439. (PMID: 35926454)
Lancet Infect Dis. 2022 Sep;22(9):1279. (PMID: 35843259)
Cell. 2020 Oct 29;183(3):730-738.e13. (PMID: 32979942)
Annu Rev Microbiol. 2002;56:677-702. (PMID: 12142481)
N Engl J Med. 2022 May 19;386(20):1910-1921. (PMID: 35320659)
Nat Mater. 2018 Feb;17(2):195-203. (PMID: 29251725)
Nat Commun. 2019 Jan 14;10(1):185. (PMID: 30643128)
Small. 2010 May 7;6(9):1044-50. (PMID: 20394070)
Emerg Microbes Infect. 2021 Dec;10(1):317-330. (PMID: 33560940)
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):. (PMID: 34292870)
ACS Cent Sci. 2023 Jul 24;9(8):1658-1669. (PMID: 37637734)
Nanoscale. 2021 Dec 13;13(47):19857-19863. (PMID: 34825689)
Nat Med. 2011 Jan;17(1):105-9. (PMID: 21151139)
Angew Chem Int Ed Engl. 2018 Sep 17;57(38):12499-12503. (PMID: 30088325)
N Engl J Med. 2008 Jul 31;359(5):463-72. (PMID: 18669425)
Sci Adv. 2020 Jan 29;6(5):eaax9318. (PMID: 32064341)
Lancet. 2022 May 21;399(10339):1937-1938. (PMID: 35533709)
Cell Rep. 2022 Apr 19;39(3):110694. (PMID: 35397208)
J Bacteriol. 1964 May;87(5):1060-6. (PMID: 4289440)
Nature. 2023 Jan;613(7944):558-564. (PMID: 36351451)
N Engl J Med. 2022 Jun 2;386(22):2097-2111. (PMID: 35507481)
PLoS One. 2022 Mar 11;17(3):e0263671. (PMID: 35275926)
فهرسة مساهمة: Keywords: Antiviral nanoparticle; Cell membrane nanodecoy; Coronavirus; Viral inactivation
تواريخ الأحداث: Date Created: 20231129 Latest Revision: 20231201
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10660003
DOI: 10.1016/j.bioactmat.2023.10.021
PMID: 38024234
قاعدة البيانات: MEDLINE
الوصف
تدمد:2452-199X
DOI:10.1016/j.bioactmat.2023.10.021